Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Femasys Inc (FEMY) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Femasys Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1339005.
Total stock buying since 2021: $2,045,000.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 41,875 | $134,000 | 0 | $0 | 0 | $0 |
| 2021 | 147,000 | $1,911,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-08 | 41,875 | $134,000 | 0 | $0 | 0 | $0 |
| 2021-06 | 147,000 | $1,911,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-08-07 | Mifek Jeffrey Gerald (Chief Clinical-Medical Affairs) | Buy | 3,125 | 3.20 | 10,000 |
| 2026-08-07 | Canning John Charles (Chief Operating Officer) | Buy | 4,375 | 3.20 | 14,000 |
| 2026-08-07 | Sipos Jeremy Alexander (Chief Technology Officer) | Buy | 3,125 | 3.20 | 10,000 |
| 2026-08-07 | Lee-sepsick Kathy (Chief Executive Officer) | Buy | 15,625 | 3.20 | 50,000 |
| 2026-08-07 | Elefant Dov (Chief Financial Officer) | Buy | 15,625 | 3.20 | 50,000 |
| 2021-06-22 | Larsen Charles | Buy | 7,000 | 13.00 | 91,000 |
| 2021-06-22 | Uzialko Edward R | Buy | 100,000 | 13.00 | 1,300,000 |
| 2021-06-22 | Adams John Q Jr | Buy | 40,000 | 13.00 | 520,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of FEMY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Femasys Inc (symbol FEMY, CIK number 1339005) see the Securities and Exchange Commission (SEC) website.